Tirzepatid · Retatrutid
Both act on the same receptors, and precisely where it matters most, retatrutide is the weaker one. That is why most switches fail right there.
34 Sources
Stacks
Combining Peptides
This page explains which peptides people combine, why they do it, and what is actually proven about it. Each page covers the mechanisms of action, the open questions, and the points where things can go wrong.
We give no dosing recommendations for combinations. What you read here describes what is practised and what is known about it.
Pre-mixed or self-combined Some stacks are offered pre-mixed: two or more peptides as a shared powder in a single vial. If you combine them yourself, you always have at least two vials and thus an additional decision: draw both peptides into one syringe, or split them into separate injections. The respective stack page explains which approach works for which combination.
GHK-Cu · TB-500 · BPC-157
The Glow Stack is a ready-made mix of the three peptides GHK-Cu, TB-500, and BPC-157 with a fixed ratio. Their mechanisms overlap more than the ads claim - and there isn't a single study on the combination.
29 Sources
GHK-Cu · BPC-157 · TB-500 · KPV
The Klow Stack combines Glow with KPV. Three of the four peptide components act on the same step of blood vessel formation, and as a mixture, this combination has not been studied in any model so far.
32 Sources
BPC-157 · GHK-Cu
BPC-157 and GHK-Cu in a study comparison: GHK-Cu has been studied on human skin, BPC-157 in animal trials via the abdominal cavity, drinking water, and vein. Injection under the skin for combined use is not proven for either substance.
29 Sources